XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.2
Restructuring charges, separation costs and impairment charges (Tables)
 6 Months Ended
Jun. 29, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve by Type of Cost
The following tables provide a summary of our cost estimates and other information associated with these plans:
2024 Footprint Realignment plan2023 Footprint Realignment plan
Plan expense estimates:(Dollars in millions)
Restructuring charges (1)
$16 million to $20 million
$4 million to $6 million
Restructuring related charges (2) (3)
$21 million to $26 million
$7 million to $9 million
Total restructuring and restructuring related charges
$37 million to $46 million
$11 million to $15 million
Other plan estimates:
Expected cash outlays
$31 million to $38 million
$11 million to $15 million
Expected capital expenditures
$15 million to $17 million
$2 million to $3 million
Other plan information:
Period initiatedMay 2024September 2023
Estimated period of substantial completionEnd of 2025End of 2027
Aggregate restructuring charges
$13.5 million
$3.2 million
Restructuring reserve:
Balance as of June 29, 2025
$10.3 million
$2.9 million
Restructuring related charges incurred:
Three months ended June 29, 2025
$2.4 million
$0.9 million
Six months ended June 29, 2025
$6.2 million
$1.5 million
Aggregate restructuring related charges
$12.8 million
$4.2 million
(1)Substantially all of the charges consist of employee termination benefit costs.
(2)2024 Footprint realignment plan restructuring related charges represent costs that are directly related to the program and consist primarily of project management costs and costs to relocate manufacturing operations and support functions to the new locations. Substantially all of the restructuring related charges are expected to be recognized within cost of goods sold.
(3)2023 Footprint realignment plan restructuring related charges represent costs that are directly related to the program and principally constitute costs to transfer manufacturing operations to existing lower-cost locations and project management costs. Substantially all of these charges are expected to be recognized within cost of goods sold.
Restructuring and Other Impairment Charges
Restructuring charges, separation costs and impairment charges recognized for the three and six months ended June 29, 2025 and June 30, 2024 consisted of the following:
Three Months Ended June 29, 2025
Termination Benefits
Other Costs (1)
Total
2024 Restructuring plan$40 $9 $49 
2024 Footprint realignment plan1,101 55 1,156 
2023 Footprint realignment plan87 — 87 
Other restructuring programs (2)
(143)16 (127)
Restructuring charges1,085 80 1,165 
Asset impairment charges— 8,117 8,117 
Separation costs— 12,890 12,890 
Restructuring charges, separation costs and impairment charges$1,085 $21,087 $22,172 
Three Months Ended June 30, 2024
Termination Benefits
Other Costs (1)
Total
2024 Footprint realignment plan$8,572 $— $8,572 
2023 Restructuring plan(974)36 (938)
2023 Footprint realignment plan588 1 589 
Other restructuring programs (3)
(373)5 (368)
Restructuring charges$7,813 $42 $7,855 
Six Months Ended June 29, 2025
Termination Benefits
Other Costs (1)
Total
2024 Restructuring plan$161 $60 $221 
2024 Footprint realignment plan2,166 92 2,258 
2023 Footprint realignment plan330 2 332 
Other restructuring programs (2)
(143)25 (118)
Restructuring charges2,514 179 2,693 
Asset impairment charges— 8,117 8,117 
Separation costs— 16,117 16,117 
Restructuring charges, separation costs and impairment charges$2,514 $24,413 $26,927 
Six Months Ended June 30, 2024
Termination Benefits
Other Costs (1)
Total
2024 Footprint realignment plan$8,572 $— $8,572 
2023 Restructuring plan(818)82 (736)
2023 Footprint realignment plan743 3 746 
Other restructuring programs (3)
(208)30 (178)
Restructuring charges8,289 115 8,404 
Asset impairment charges— 2,110 2,110 
Restructuring and impairment charges$8,289 $2,225 $10,514 
(1) Other costs include facility closure, contract termination and other exit costs.
(2) Includes activity primarily related to our 2023 Restructuring plan and our Respiratory divestiture plan.
(3) Includes activity primarily related to our 2022 Restructuring plan, which has concluded.